A Game Changer for Follicular Lymphoma: Mastering Use of Precision Therapies as Part of a Chemo-Free Treatment Paradigm

Deepen your understanding of current and emerging chemo-free treatment strategies for patients with relapsed/refractory follicular lymphoma and learn how to appropriately manage the treatment-related toxicities to maximize outcomes. After the live webinar, view the on-demand webcast, download the associated slideset for use in your clinic, and review the expert-authored answers to frequently asked questions.

Share

Program Content

Activities

Clinical Needs and Targeted Therapies for RR FL
Overview, Unmet Needs, Current Landscape and Treatment With Targeted Therapies in R/R FL
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 04, 2024

Expires: December 03, 2025

Bispecific Antibodies in RR FL
Integrating Bispecific Antibodies Into the Treatment of Patients With R/R FL
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 04, 2024

Expires: December 03, 2025

CAR T Cell Tx in RR FL
Optimizing CAR T-Cell Therapies in R/R FL
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 04, 2024

Expires: December 03, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC in partnership with Follicular Lymphoma Foundation.

Supporters

Supported by educational grants from AstraZeneca; Genmab US, Inc.; and Ipsen Biopharmaceuticals, Inc.

AstraZeneca

Genmab US, Inc.

Ipsen Biopharmaceuticals Inc

Partners

Follicular Lymphoma Foundation

ProCE Banner